185 related articles for article (PubMed ID: 18210332)
1. The investigation and management of severe hyperandrogenism pre- and postmenopause: non-tumor disease is strongly associated with metabolic syndrome and typically responds to insulin-sensitization with metformin.
Vaikkakara S; Al-Ozairi E; Lim E; Advani A; Ball SG; James RA; Quinton R
Gynecol Endocrinol; 2008 Feb; 24(2):87-92. PubMed ID: 18210332
[TBL] [Abstract][Full Text] [Related]
2. Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome.
Kazerooni T; Dehghan-Kooshkghazi M
Gynecol Endocrinol; 2003 Feb; 17(1):51-6. PubMed ID: 12724019
[TBL] [Abstract][Full Text] [Related]
3. Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.
Wu J; Zhu Y; Jiang Y; Cao Y
Gynecol Endocrinol; 2008 Jul; 24(7):392-8. PubMed ID: 18608522
[TBL] [Abstract][Full Text] [Related]
4. Effect of metformin administration on plasma advanced glycation end product levels in women with polycystic ovary syndrome.
Diamanti-Kandarakis E; Alexandraki K; Piperi C; Aessopos A; Paterakis T; Katsikis I; Panidis D
Metabolism; 2007 Jan; 56(1):129-34. PubMed ID: 17161235
[TBL] [Abstract][Full Text] [Related]
5. Metformin administration is more effective when non-obese patients with polycystic ovary syndrome show both hyperandrogenism and hyperinsulinemia.
Genazzani AD; Lanzoni C; Ricchieri F; Baraldi E; Casarosa E; Jasonni VM
Gynecol Endocrinol; 2007 Mar; 23(3):146-52. PubMed ID: 17454168
[TBL] [Abstract][Full Text] [Related]
6. Homocysteine levels are unaffected by metformin treatment in both nonpregnant and pregnant women with polycystic ovary syndrome.
Carlsen SM; Kjøtrød S; Vanky E; Romundstad P
Acta Obstet Gynecol Scand; 2007; 86(2):145-50. PubMed ID: 17364275
[TBL] [Abstract][Full Text] [Related]
7. Does metformin induce ovulation in normoandrogenic anovulatory women?
Carmina E; Lobo RA
Am J Obstet Gynecol; 2004 Nov; 191(5):1580-4. PubMed ID: 15547527
[TBL] [Abstract][Full Text] [Related]
8. Metformin effects on clomifene-induced ovulation in the polycystic ovary syndrome.
Ben Ayed B; Dammak dit Mlik S; Ben Arab H; Trabelssi H; Chahtour H; Mathlouthi N; Dhuib M; Kassis M; Saiidane D; Trabelssi K; Guermazi M
Tunis Med; 2009 Jan; 87(1):43-9. PubMed ID: 19522426
[TBL] [Abstract][Full Text] [Related]
9. Effects of androgens on insulin action in women: is androgen excess a component of female metabolic syndrome?
Corbould A
Diabetes Metab Res Rev; 2008 Oct; 24(7):520-32. PubMed ID: 18615851
[TBL] [Abstract][Full Text] [Related]
10. Effect of metformin, orlistat and pioglitazone treatment on mean insulin resistance and its biological variability in polycystic ovary syndrome.
Cho LW; Kilpatrick ES; Keevil BG; Coady AM; Atkin SL
Clin Endocrinol (Oxf); 2009 Feb; 70(2):233-7. PubMed ID: 18547343
[TBL] [Abstract][Full Text] [Related]
11. Does metformin augment the ovulation inducing effects of clomiphene in non-obese women with polycystic ovary syndrome?
Chaudhury K; Chaudhury S; Chowdhury S
J Indian Med Assoc; 2008 Oct; 106(10):643-4, 646-8. PubMed ID: 19552097
[TBL] [Abstract][Full Text] [Related]
12. High neutrophil count in girls and women with hyperinsulinaemic hyperandrogenism: normalization with metformin and flutamide overcomes the aggravation by oral contraception.
Ibáñez L; Jaramillo AM; Ferrer A; de Zegher F
Hum Reprod; 2005 Sep; 20(9):2457-62. PubMed ID: 15905296
[TBL] [Abstract][Full Text] [Related]
13. Low-dose flutamide-metformin therapy for hyperinsulinemic hyperandrogenism in non-obese adolescents and women.
Ibáñez L; de Zegher F
Hum Reprod Update; 2006; 12(3):243-52. PubMed ID: 16407452
[TBL] [Abstract][Full Text] [Related]
14. Normalization of metabolic syndrome using fenofibrate, metformin or their combination.
Nieuwdorp M; Stroes ES; Kastelein JJ;
Diabetes Obes Metab; 2007 Nov; 9(6):869-78. PubMed ID: 17924869
[TBL] [Abstract][Full Text] [Related]
15. Additive effects of insulin-sensitizing and anti-androgen treatment in young, nonobese women with hyperinsulinism, hyperandrogenism, dyslipidemia, and anovulation.
Ibáñez L; Valls C; Ferrer A; Ong K; Dunger DB; De Zegher F
J Clin Endocrinol Metab; 2002 Jun; 87(6):2870-4. PubMed ID: 12050266
[TBL] [Abstract][Full Text] [Related]
16. Severe hyperandrogenemia and insulin resistance in a 12-year-old girl.
Veilleux-Lemieux M; DiVasta AD
J Pediatr Adolesc Gynecol; 2012 Aug; 25(4):e99-101. PubMed ID: 22840945
[TBL] [Abstract][Full Text] [Related]
17. Ovarian Leydig cell tumor in a peri-menopausal woman with severe hyperandrogenism and virilization.
Nardo LG; Ray DW; Laing I; Williams C; McVey RJ; Seif MW
Gynecol Endocrinol; 2005 Oct; 21(4):238-41. PubMed ID: 16316848
[TBL] [Abstract][Full Text] [Related]
18. The management of insulin resistance in polycystic ovary syndrome.
Teede HJ; Hutchison SK; Zoungas S
Trends Endocrinol Metab; 2007 Sep; 18(7):273-9. PubMed ID: 17698366
[TBL] [Abstract][Full Text] [Related]
19. Effect of different doses of metformin on serum testosterone and insulin in non-diabetic women with breast cancer: a randomized study.
Campagnoli C; Pasanisi P; Abbà C; Ambroggio S; Biglia N; Brucato T; Colombero R; Danese S; Donadio M; Venturelli E; Zito G; Berrino F
Clin Breast Cancer; 2012 Jun; 12(3):175-82. PubMed ID: 22607767
[TBL] [Abstract][Full Text] [Related]
20. Low-dose flutamide-metformin therapy reverses insulin resistance and reduces fat mass in nonobese adolescents with ovarian hyperandrogenism.
Ibáñez L; Ong K; Ferrer A; Amin R; Dunger D; de Zegher F
J Clin Endocrinol Metab; 2003 Jun; 88(6):2600-6. PubMed ID: 12788862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
